PAHC — PHIBRO ANIMAL HEALTH CORP

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1069899 ·
Last close
$34.92
Market Cap
$737.01M
52W High
$59.64
52W Low
$28.04
ADV30
212,053
Next earnings
2027-02-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 386,774,000 128,537,000 49,639,000 29,520,000 1,514,722,000 75,548,000 1,097,054,000
Jun 2026 396,747,000 134,401,000 48,157,000 21,710,000 1,501,241,000 61,419,000 1,115,764,000
Mar 2026 383,543,000 125,675,000 44,653,000 24,024,000 1,445,118,000 54,929,000 1,083,291,000
Dec 2025 373,910,000 132,656,000 50,326,000 27,459,000 1,405,553,000 55,486,000 1,073,192,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$85,734,000
Investing CF
$-56,388,000
Financing CF
$-28,529,000
CapEx
$-64,064,000
Dividends Paid
$-19,471,000
Buybacks
—
EPS Diluted TTM
$2.51
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$377,606,000
Inventory
$567,139,000
Receivables
$221,710,000
ST Investments
$7,575,000
EBIT TTM
$183,553,000
Pretax Income TTM
$139,856,000
Interest Exp TTM
$43,697,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,540,973,952
EBITDA
$246,476,000
Free Cash Flow
$-4,774,875
Enterprise Value
$2,044,616,832
Total Cash
$87,114,000
Total Debt
$793,502,016
Shares Out
21,105,569
Trailing EPS
$2.51
Book Value
$10.29
ROE
28.2%
ROA
8.4%
Div Yield
1.46%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 1,518,093,000 194,396,000 99,720,000 1,501,241,000 1,115,764,000 385,477,000 68,954,000
Jun 2025 1,296,215,000 110,465,000 48,264,000 1,360,900,000 1,075,218,000 285,682,000 80,124,000
Jun 2024 1,017,679,000 53,315,000 2,416,000 982,184,000 725,543,000 256,641,000 87,594,000
Jun 2023 977,889,000 71,847,000 32,606,000 971,397,000 688,888,000 282,509,000 13,310,000

TTM Snapshot

Revenues TTM
$1,518,093,000
NetIncome TTM
$99,720,000
OpCashFlow TTM
—
Assets (Latest)
$1,445,118,000
Forward EPS
$3.85

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $22.50 · spot: $35.57 · call volume: 66 · put volume: 21
Expected Move to 2026-12-18: ±$4.78 (13.42%) — implied range $30.79 – $40.34 · ATM straddle on $35.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
APMD Apnimed, Inc. $741.03M $17.80 —
OBX Obsidian Therapeutics, Inc. $745.61M $12.07 —
IVEVF Inventiva S.A. $751.18M $3.18 —
IVA Inventiva S.A. $760.63M $3.22 —
SGMT Sagimet Biosciences Inc. $702.97M $9.85 —

News headlines (Yahoo Finance, 1h cache)

Interpreting Phibro (PAHC) International Revenue Trends
2026-11-09 13:15 · Yahoo
Phibro: 3 Key Takeaways for Long-Term Investors
2026-11-09 12:43 · Yahoo
5 must-read analyst questions from Phibro Animal Health’s Q3 CY2026 earnings call
2026-11-08 20:29 · Yahoo
Phibro Animal (PAHC) Q1 2027 Earnings Call Transcript
2026-11-07 17:32 · Yahoo
Phibro Animal Health Corp (PAHC) (Q1 2027) Earnings Call Highlights: Solid Start to Fiscal 2027 ...
2026-11-07 01:11 · Yahoo
What Phibro Animal Health (PAHC) Said on Its Q1 Earnings Call
2026-11-05 22:14 · Yahoo
Phibro Animal Health Corporation Q1 2027 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Phibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to Say
2026-11-05 00:30 · Yahoo
Phibro: Fiscal Q1 Earnings Snapshot
2026-11-04 21:52 · Yahoo
Phibro Animal Health (NASDAQ:PAHC) exceeds Q3 CY2026 expectations
2026-11-04 21:34 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.